Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Gynecol Oncol. 2021 Nov 8;164(1):12–17. doi: 10.1016/j.ygyno.2021.10.087

Table 2:

Median PFS and percentage of patients progression free at 6 months by quartile of AR expression.

% AR Expression N Progression/Death Median PFS (90%CI) PFS6 (90%CI) Logrank P value
<25% 14 12 1.7 (1.6-Inf) 23.1% (5.6–100%) 0.81
25–60% 15 14 1.9 (1.6-Inf) 13.3% (2.2–100%)
60–80% 13 11 3.5 (1.6-Inf) 33.3% (10.3–100%)
>=80% 17 17 3.7 (1.6-Inf) 29.4% (10.7–100%)